Skip to main content

More Filters

1,092 results

Showing: 821 - 840 of 1092 results
  1. pAAV.CAG.iAChSnFR (AAV1)

    Viral Prep
    #137955-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV.CAG.iAChSnFR (#137955). In addition to the viral particles, you will also receive purified pAAV.CAG.iAChSnFR plasmid DNA. CAG-driven iAChSnFR acetylcholine sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV-EF1a-vCre (AAV8)

    Viral Prep
    #55638-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-EF1a-vCre (#55638). In addition to the viral particles, you will also receive purified pAAV-EF1a-vCre plasmid DNA. EF1a-driven expression of VCre. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Nov. 12, 2020
    Availability
    Academic Institutions and Nonprofits only
  3. pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 (AAV5)

    Viral Prep
    #98930-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 (#98930). In addition to the viral particles, you will also receive purified pENN.AAV.GFAP.iGluSnFr.WPRE.SV40 plasmid DNA. GFAP-driven glutamate sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available Since
    Feb. 27, 2018
    Availability
    Academic Institutions and Nonprofits only
  4. pGP-AAV-CAG-FLEX-jGCaMP8s-WPRE (AAV Retrograde)

    Viral Prep
    #162380-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pGP-AAV-CAG-FLEX-jGCaMP8s-WPRE (#162380). In addition to the viral particles, you will also receive purified pGP-AAV-CAG-FLEX-jGCaMP8s-WPRE plasmid DNA. CAG-driven, Cre-dependent expression of calcium sensor GCaMP8s (more sensitive). These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    June 22, 2021
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV_BiPVe4_GCaMP6f (AAV1)

    Viral Prep
    #213939-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV-hsyn-flex-Voltron-ST (AAV1)

    Viral Prep
    #119036-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hsyn-flex-Voltron-ST (#119036). In addition to the viral particles, you will also receive purified pAAV-hsyn-flex-Voltron-ST plasmid DNA. Synapsin-driven, cre-dependent expression of genetically encoded fluorescent voltage indicator Voltron1 with a soma-targeting sequence. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    April 10, 2019
    Availability
    Academic Institutions and Nonprofits only
  7. pGP-AAV-syn-FLEX-jGCaMP7c variant 1513-WPRE (AAV1)

    Viral Prep
    #105322-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-syn-FLEX-jGCaMP7c variant 1513-WPRE (#105322). In addition to the viral particles, you will also receive purified pGP-AAV-syn-FLEX-jGCaMP7c variant 1513-WPRE plasmid DNA. Synapsin-driven, Cre-dependent jGCaMP7c expression. jGCaMP7c exhibits high contrast between peak fluorescence and resting fluorescence. It is useful for activity imaging of large populations of densely-labeled neurons because background fluorescence from inactive neurons is reduced. These AAV preparations are suitable purity for injection into animals.
    Promoter
    Syn
    Available Since
    June 13, 2019
    Availability
    Academic Institutions and Nonprofits only
  8. pGP-AAV-CAG-FLEX-jGCaMP7f-WPRE (AAV PHP.eB)

    Viral Prep
    #104496-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pGP-AAV-CAG-FLEX-jGCaMP7f-WPRE (#104496). In addition to the viral particles, you will also receive purified pGP-AAV-CAG-FLEX-jGCaMP7f-WPRE plasmid DNA. CAG-driven, Cre-dependent jGCaMP7f calcium sensor. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Promoter
    CAG
    Available Since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV-hSyn-dLight1.1 (AAV1)

    Viral Prep
    #111066-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn-dLight1.1 (#111066). In addition to the viral particles, you will also receive purified pAAV-hSyn-dLight1.1 plasmid DNA. hSyn-driven expression of dLight1.1 dopamine sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available Since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only
  10. pENN.AAV.EF1a.eGFP.WPRE.rBG (AAV Retrograde)

    Viral Prep
    #105547-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pENN.AAV.EF1a.eGFP.WPRE.rBG (#105547). In addition to the viral particles, you will also receive purified pENN.AAV.EF1a.eGFP.WPRE.rBG plasmid DNA. EF1a-driven EGFP expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    EGFP
    Available Since
    Oct. 18, 2021
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV-mDlx-GFP-Fishell-1 (AAV8)

    Viral Prep
    #83900-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    mDlx
    Available Since
    May 22, 2023
    Availability
    Academic Institutions and Nonprofits only
  12. pAAV-CaMKIIa-hChR2(H134R)-mCherry (AAV1)

    Viral Prep
    #26975-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CaMKIIa-hChR2(H134R)-mCherry (#26975). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-mCherry plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to mCherry for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    mCherry
    Available Since
    Feb. 15, 2018
    Availability
    Academic Institutions and Nonprofits only
  13. pAAV-hDlx-GqDREADD-dTomato-Fishell-4 (AAV Retrograde)

    Viral Prep
    #83897-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-hDlx-GqDREADD-dTomato-Fishell-4 (#83897). In addition to the viral particles, you will also receive purified pAAV-hDlx-GqDREADD-dTomato-Fishell-4 plasmid DNA. hDlx-driven expression of GqDREADD (hM3D) and nuclear localized dTomato (physically separate) for activation of interneurons. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    hDlx
    Tags
    dTomato
    Available Since
    Aug. 28, 2020
    Availability
    Academic Institutions and Nonprofits only
  14. pAAV-nEF-NpHR3.3-EYFP (AAV8)

    Viral Prep
    #137151-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-nEF-NpHR3.3-EYFP (#137151). In addition to the viral particles, you will also receive purified pAAV-nEF-NpHR3.3-EYFP plasmid DNA. nEF-driven expression of NpHR3.3-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Promoter
    nEF
    Tags
    EYFP
    Available Since
    May 5, 2021
    Availability
    Academic Institutions and Nonprofits only
  15. pAAV-hSyn-dF-HA-KORD-IRES-mCitrine (AAV Retrograde)

    Viral Prep
    #65417-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-hSyn-dF-HA-KORD-IRES-mCitrine (#65417). In addition to the viral particles, you will also receive purified pAAV-hSyn-dF-HA-KORD-IRES-mCitrine plasmid DNA. hSyn-driven, Cre-dependent KORD expression with bicistronic mCitrine, for SALB-induced neuronal inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCitrine
    Available Since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only
  16. pAAV.CAG.FLEX.iGluSnFR3.v857.PDGFR (AAV2)

    Viral Prep
    #196219-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV.CAG.FLEX.iGluSnFR3.v857.PDGFR (#196219). In addition to the viral particles, you will also receive purified pAAV.CAG.FLEX.iGluSnFR3.v857.PDGFR plasmid DNA. CAG-driven, Cre-dependent third generation glutamate sensor iGluSnFR3, variant 857. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available Since
    Aug. 6, 2025
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV_BiSSTe4_ChR2_mCherry (AAV1)

    Viral Prep
    #213945-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiSSTe4_ChR2_mCherry (#213945). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the SST interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tags
    mCherry
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  18. pAAV_BiPVe3_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213943-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe3_GCaMP6f (#213943). In addition to the viral particles, you will also receive purified pAAV_BiPVe3_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the PV+ basket cell-targeting enhancer E3. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  19. pENN.AAV.CMVs.TurboRFP.WPRE.RBG (AAV8)

    Viral Prep
    #105548-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pENN.AAV.CMVs.TurboRFP.WPRE.RBG (#105548). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.TurboRFP.WPRE.RBG plasmid DNA. CMV-driven TurboRFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    TurboRFP
    Available Since
    June 29, 2018
    Availability
    Academic Institutions and Nonprofits only
  20. pAAV-FLEX-P301L Tau (AAV1)

    Viral Prep
    #176267-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-FLEX-P301L Tau (#176267). In addition to the viral particles, you will also receive purified pAAV-FLEX-P301L Tau plasmid DNA. EF1a-driven, Cre-dependent expression of human 2N4R microtubule-associated protein tau with P301L mutation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available Since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 821 - 840 of 1092 results